| 000 | 01227 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513044938.0 | ||
| 264 | 0 | _c19950217 | |
| 008 | 199502s 0 0 eng d | ||
| 022 | _a0361-7742 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBucklin, S E | |
| 245 | 0 | 0 |
_aParticipation of IFN-gamma in the pathogenesis of LPS lethality. _h[electronic resource] |
| 260 |
_bProgress in clinical and biological research _c1994 |
||
| 300 |
_a399-406 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xetiology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInterferon-gamma _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLipopolysaccharides _xtoxicity |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aReceptors, Interferon _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aShock, Septic _xetiology |
| 650 | 0 | 4 | _aInterferon gamma Receptor |
| 700 | 1 | _aRussell, S W | |
| 700 | 1 | _aMorrison, D C | |
| 773 | 0 |
_tProgress in clinical and biological research _gvol. 388 _gp. 399-406 |
|
| 999 |
_c7830713 _d7830713 |
||